| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 04/18/2002 | CA2424107A1 Sulfonylguanidines |
| 04/17/2002 | EP1196379A2 INHIBITORS OF FACTOR Xa |
| 04/17/2002 | EP0655061B1 Method of increasing the spf rating and compounds suitable for increasing the spf rating of fibre or fabric |
| 04/17/2002 | CN1345309A Diaryl derivatives and their use as medicaments |
| 04/17/2002 | CN1345308A Acetylenic alpha-amino acid based sulfonamide hydroxamic acid TACE inhibitors |
| 04/17/2002 | CN1345303A Oxamic acids and derivatives as thyroid receptor ligands |
| 04/17/2002 | CN1082790C Herbicides |
| 04/16/2002 | US6372779 Anthracene derivatives with carbamoyl groups, amido groups, urea groups and sulfonamide groups |
| 04/16/2002 | US6372778 Sulfonamide inhibitors of aspartyl protease |
| 04/16/2002 | CA2009690C Phenylhydrazones, the manufacture thereof and therapeutic and cosmetic compositions prepared therefrom |
| 04/15/2002 | WO2002030514A2 Insulin receptor activators for the treatment of metabolic disorders in humans resulting from treatment of hiv infection with hiv protease inhibitors |
| 04/15/2002 | CA2421622A1 Insulin receptor activators for the treatment of metabolic disorders in humans resulting from treatment of hiv infection with hiv protease inhibitors |
| 04/11/2002 | WO2002028827A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 04/11/2002 | WO2002028825A2 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
| 04/11/2002 | WO2002028820A1 Nitroso diphenylamine derivatives |
| 04/11/2002 | WO2002028810A2 Retinoids for the treatment of emphysema |
| 04/11/2002 | WO2001090055A3 A process for preparing biphenyl compounds |
| 04/11/2002 | US20020042517 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 04/11/2002 | DE10047486A1 Phenoxyphenyl Alkansulfonate Phenoxy-phenyl alkane |
| 04/11/2002 | DE10046993A1 Substituierte Zimtsäureguanidide, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltendes Medikament Substituted Zimtsäureguanidide, processes for their preparation, their use as a medicament and they drug-containing |
| 04/11/2002 | CA2424684A1 Nitroso diphenylamine derivatives |
| 04/11/2002 | CA2423883A1 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
| 04/10/2002 | EP1195371A1 Process for the preparation of tricyclic amino alcohol derivatives |
| 04/10/2002 | EP1194414A1 Process for preparing 2-amino-4-(4-fluorphenyl)-6-alkylpyrimidine-5-carboxylate |
| 04/10/2002 | EP1194404A1 Inhibitors of aspartyl protease |
| 04/10/2002 | EP1194403A1 Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same |
| 04/10/2002 | CN1344250A 间苯二酚衍生物 Resorcinol derivatives |
| 04/09/2002 | US6369248 Fragrance precursor compounds |
| 04/09/2002 | US6369073 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 04/09/2002 | US6369069 Cardiovascular disorders |
| 04/09/2002 | CA2090321C Therapeutically useful 2-aminotetralin derivatives |
| 04/04/2002 | WO2002026701A2 Ionic liquids and their use as solvents |
| 04/04/2002 | WO2002004407A3 7-substituted tetracycline compounds |
| 04/04/2002 | WO2002000167A3 Modified forms of pharmacologically active agents and uses therefor |
| 04/04/2002 | WO2001094301A3 Factor viia inhibitory (thio)urea derivatives, their preparation and their use |
| 04/04/2002 | WO2001064643A3 Benzamides and related inhibitors of factor xa |
| 04/04/2002 | US20020040043 Amidino derivatives and their use as thrombin inhibitors |
| 04/04/2002 | US20020040003 Tyrosine phosphatase inhibitors useful in the treatment or prevention of Type II Diabetes Mellitus |
| 04/03/2002 | EP1192137A1 COMPOUNDS FOR THE MODULATION OF PPAR$g(g) ACTIVITY |
| 04/03/2002 | EP0948482B1 Method for producing trifluoroacetoacetic acid anilides |
| 04/03/2002 | EP0874645B1 Perfluoroalkyl-containing metal complexes and their use in nmr diagnostics |
| 04/02/2002 | US6365693 Fluoropolymers |
| 04/02/2002 | US6365068 Heterocyclic aromatic anion salts, and their uses as ionic conducting materials |
| 03/28/2002 | WO2002024672A2 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 03/28/2002 | WO2002024636A2 N-acylsulfonamide apoptosis promoters |
| 03/28/2002 | WO2002024635A2 Aminoalcohol derivatives |
| 03/28/2002 | WO2002024613A2 Resorcinol derivatives |
| 03/28/2002 | US20020038053 For use in enantioselective reduction of prochiral ketones to chiral secondary alcohols |
| 03/28/2002 | US20020038025 For therapy and prophylaxis of hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, parasite infections, gallstones, tumors and/or hyperproliferative disorders, diabetes |
| 03/28/2002 | US20020037905 N-phenyl-N'-(2-carboxyphenyl) urea, for example; chloride channel blockers; such as for treating bone metabolic disorders |
| 03/28/2002 | US20020037574 Recombinant C-proteinase and processes, methods and uses thereof |
| 03/28/2002 | CA2423262A1 Resorcinol derivatives |
| 03/28/2002 | CA2416136A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 03/27/2002 | EP1191611A2 Piezoelectric element and process for production thereof |
| 03/27/2002 | EP1190710A1 Preventive or therapeutic drugs for diabetes |
| 03/27/2002 | EP1189879A1 INHIBITORS OF FACTOR Xa |
| 03/27/2002 | EP0882011B1 Process for preparing n-(3-amino-4-chlorophenyl) acylamides |
| 03/27/2002 | CN1342139A Serine protease inhibitors |
| 03/27/2002 | CN1341593A Proteinase inhibitor |
| 03/27/2002 | CN1341592A Proteinase inhibitor |
| 03/27/2002 | CN1341591A Solution of tetrahydrate N-[ortho-(para-trimethyl acetoxyl benzenesulfonamide) benzoyl] glycine monosodium salt and its medicine |
| 03/27/2002 | CN1341590A Proteinase inhibitor |
| 03/27/2002 | CN1081625C 1-aryl-2-acylamino-ethane compounds and their use as meurokinin especially neurokinin 1 antagonists |
| 03/26/2002 | US6362371 β2- adrenergic receptor agonists |
| 03/26/2002 | US6362360 Sensitizers for insulin resistance and associated conditions dyslipidemia and hyperglycemia |
| 03/26/2002 | US6362230 Alzheimer's disease |
| 03/26/2002 | US6362210 Carboxylic acid amides, pharmaceutical compositions containing these compounds and their use |
| 03/26/2002 | US6362209 Heterocyclic aromatic oxazole compounds and use thereof |
| 03/26/2002 | US6361919 Silver halide photographic light sensitive material and hydrazine compound employed in it |
| 03/21/2002 | WO2002022623A1 4-cyclohexyl-1,3,2-oxazaborolidine chiral accessories |
| 03/21/2002 | WO2002022592A2 Substituted urea neuropeptide y y5 receptor antagonists |
| 03/21/2002 | WO2002022566A1 Rare-earth ternary complex |
| 03/21/2002 | WO2002022565A1 Inhibitors of rho c |
| 03/21/2002 | WO2002022551A1 Derivatives of naphthalene with comt inhibiting activity |
| 03/21/2002 | WO2002021918A1 Fungicidal compositions |
| 03/21/2002 | US20020035137 Amino (oxo) acetic acid protein tyrosine phosphatase inhibitors |
| 03/21/2002 | US20020035136 Amino(oxo) acetic acid protein tyrosine phosphatase inhibitors |
| 03/21/2002 | US20020034764 Diarylsulfonylurea binding proteins |
| 03/21/2002 | CA2422013A1 Substituted urea neuropeptide y y5 receptor antagonists |
| 03/21/2002 | CA2421777A1 4-cyclohexyl-1,3,2-oxazaborolidine chiral accessories |
| 03/21/2002 | CA2421226A1 Fungicidal compositions |
| 03/21/2002 | CA2417716A1 Mri method involving the use of a hyperpolarized contrast agent |
| 03/20/2002 | EP1187531A1 Macrophage scavenger receptor antagonists |
| 03/20/2002 | EP0944590B1 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 03/20/2002 | CN1341098A W-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 03/20/2002 | CN1341094A Monoamine reuptake inhibitors for treatment of CNS disorders |
| 03/19/2002 | US6359158 A 16-hydroxyeicosatetraenoic acid antagonist; antiinflammatory agents |
| 03/19/2002 | US6358987 For therapy and prophylaxis of rheumatoid arthritis, osteoarthritis, osteopenias such as osteoporosis, periodontitis, gingivitis, corneal epidermal or gastric ulceration, and tumour metastasis, invasion and growth |
| 03/19/2002 | US6358981 Sulphonamide derivatives |
| 03/19/2002 | US6358960 For therapy of intravascular coagulation, coronary thrombosis, cerebral infarction, cerebral embolism, transient ischemic attack, cerebrovascular disorders, pulmonary vascular diseases, deep venous thrombosis, etc. |
| 03/14/2002 | WO2002020474A2 Resorcinol derivatives |
| 03/14/2002 | WO2002020463A2 Fxr modulators |
| 03/14/2002 | US20020032238 Lowering the plasma level of atherogenic lipoproteins; treating hyperlipidaemias, atherosclerosis or the clinical sequelae thereof, diabetes mellitus, adiposity or pancreatitis |
| 03/13/2002 | EP1186305A1 New brominated compounds as contrast media for X-ray mammography |
| 03/13/2002 | EP1185518A1 Alpha-phenyl-beta-ketosulfone |
| 03/13/2002 | EP1185512A2 INHIBITORS OF FACTOR Xa |
| 03/13/2002 | EP1185511A2 Inhibitors of factor xa |
| 03/13/2002 | EP1185509A2 INHIBITORS OF FACTOR Xa |
| 03/13/2002 | EP1185508A2 Inhibitors of factor xa |
| 03/13/2002 | EP1185488A1 Sulphonylamides and carboxamides and their use in asymmetrical catalysis |